Experimental inflammation of the rat distal colon inhibits ion secretion in the proximal colon by affecting the enteric nervous system.
Intestinal inflammation causes hyporesponsiveness of the inflamed tissue to secretagogues but little is known about the behaviour of the areas proximal to the site of inflammation. We studied the responses of the proximal segment of the colon to carbachol, histamine, isobutylmethylxanthine (IBMX) and vasoactive intestinal peptide (VIP) in rats with trinitrobenzenesulphonic acid (TNBS)-induced, chronic inflammation of the distal colon. Macroscopic and biochemical analysis ruled out the presence of inflammation in the proximal colon. When mounted in Ussing chambers under voltage-clamp conditions, basal transport and conductance were not affected. However, the maximum response in the concentration/response curves (short-circuit current) for carbachol and histamine was reduced in TNBS-treated rats, without changes in the EC(50). This effect corresponded to reduced chloride secretion, as demonstrated by ion substitution experiments. The responses to IBMX and VIP were virtually unaffected. The inhibitory effect was abolished by pretreatment with the neural blockers tetrodotoxin and lidocaine but not indomethacin, suggesting that the enteric nervous system is responsible for the inhibition. In conclusion, chronic distal inflammation of the distal colon results in inhibition of calcium-dependent secretion in the proximal colon via a reduction of the contribution of the enteric nervous system.
Pérez-Navarro
R
R
Department of Pharmacology, School of Pharmacy, University of Granada, Campus de Cartuja s/n, 18071 Granada, Spain.
Martínez-Augustin
O
O
Ballester
I
I
Zarzuelo
A
A
Sánchez de Medina
F
F
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D018679:Cholinergic Agonists / Q000494:pharmacology; D003106:Colon / Q000187:drug effects*; D003108:Colonic Diseases / Q000139:chemically induced / Q000201:enzymology / Q000378:metabolism*; D005260:Female; D005978:Glutathione / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000201:enzymology / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D009195:Peroxidase / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D018679:Cholinergic Agonists; D010726:Phosphodiesterase Inhibitors; D014660:Vasoactive Intestinal Peptide; D006632:Histamine; D002217:Carbachol; D009195:Peroxidase; D005978:Glutathione; D015056:1-Methyl-3-isobutylxanthine
Am J Physiol. 1998 Dec;275(6 Pt 1):G1274-81
9843763
Pflugers Arch. 2002 Jun;444(3):378-88
12111246
Eur J Pharmacol. 1989 Sep 13;168(2):219-29
2606150
Gastroenterology. 1984 Dec;87(6):1344-50
6092199
Dig Dis Sci. 2003 Apr;48(4):743-9
12741465
Ann N Y Acad Sci. 1992;664:210-21
1456652
Life Sci. 2002 May 17;70(26):3097-108
12008093
Am J Physiol. 1995 Apr;268(4 Pt 1):G622-30
7733288
Gut. 1993 Apr;34(4):503-8
8491398
Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G850-60
12869384
Eur J Pharmacol. 1995 Feb 14;274(1-3):181-91
7539376
Gastroenterology. 2000 Feb;118(2 Suppl 1):S68-82
10868899
Acta Gastroenterol Belg. 2001 Apr-Jun;64(2):155-9
11475125
J Pharmacol Exp Ther. 1996 Aug;278(2):771-9
8768730
Inflammation. 1995 Apr;19(2):245-59
7541393
Annu Rev Physiol. 2000;62:535-72
10845102
Annu Rev Physiol. 2000;62:467-91
10845099
J Physiol. 1986 Jul;376:531-42
2432239
Gastroenterology. 1995 Sep;109(3):718-22
7657099
Gut. 1979 Jun;20(6):484-8
468074
J Pharm Pharmacol. 1988 Feb;40(2):106-10
2897440
Methods Enzymol. 1981;77:373-82
7329314
J Physiol. 1985 Jul;364:301-12
2411917
Gastroenterology. 1989 Mar;96(3):795-803
2914642